Michael J Naughton MD

Assistant Professor, Internal Medicine, Washington University School of Medicine

211 Saint Francis Dr Ste 372Cape Girardeau, MO 63703
Phone+1 573-331-5525
Fax+1 573-331-5558

Dr. Naughton is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Naughton's full profile Already have an account?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1996 - 2000
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1996 - 1999
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1993 - 1996
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1993

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 1996 - 2027
CA State Medical License 2015 - 2021
OH State Medical License 2000 - 2010
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2017
CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013-2017
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017

Clinical Trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
ACTIVE_NOT_RECRUITING
PHASE3
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Start of enrollment: 2005 Sep 14
RECRUITING
Intensity Modulated Radiotherapy for Breast Cancer Start of enrollment: 2008 Jan 04
Completed
Phase 1

Publications & Presentations

PubMed

Stereotactic Body Radiation Therapy for Palliative Reirradiation of Acrometastasis in the Hand From Breast Cancer.
Thomas R Mazur, H Michael Gach, Joshua P Schiff, Laura L Ochoa, Michael J Naughton
Advances in Radiation Oncology. 2024-12-01
3 citations
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Paula M Fracasso, Sherry A Goodner, Jonathan D Wildi, Michael J Naughton, Gerald P Linette
American Journal of Clinical Oncology. 2022-07-01
4 citations
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.
Manik Amin, Feng Gao, Gretel Terrero, Joel Picus, Andrea Wang-Gillam
American Journal of Clinical Oncology. 2021-09-01